Carol Tamminga
#55,491
Most Influential Person Now
American psychiatrist and neuroscientist
Carol Tamminga's AcademicInfluence.com Rankings
Carol Tammingabiology Degrees
Biology
#3011
World Rank
#4669
Historical Rank
#1276
USA Rank
Neuroscience
#433
World Rank
#452
Historical Rank
#141
USA Rank
Download Badge
Biology
Why Is Carol Tamminga Influential?
(Suggest an Edit or Addition)According to Wikipedia, Carol A. Tamminga is an American psychiatrist and neuroscientist, focusing in treating psychotic illnesses, such as schizophrenia, psychotic bipolar disorder, and schizoaffective disorder, currently the Lou and Ellen McGinley Distinguished Chair in Psychiatric Research and the Chief of the Translational Neuroscience Division in Schizophrenia at University of Texas Southwestern Medical Center. She has been Chair of the Department of Psychiatry at UTSW since 2008. She is an Elected Fellow of the National Academy of Medicine. She serves on the advisory boards of the Brain and Behavioral Research Foundation and of the National Institute of Mental Health . In 2011 she was awarded the Lieber Prize for Outstanding Achievement in Schizophrenia Research. Tamminga led a study examining whether giving Prozac to fetuses with Down syndrome would improve the functioning of their brains. In her attempt to confirm psychiatric diagnoses biologically, she found "biotypes" or "clusters." Her current research involves mechanisms underlying schizophrenia, especially its most prominent symptoms, psychosis and memory dysfunction.
Carol Tamminga's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions (2007) (1824)
- Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. (1986) (922)
- Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia (1995) (901)
- Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. (2003) (794)
- Effects of Ketamine in Normal and Schizophrenic Volunteers (2001) (625)
- Antidepressant Actions of Histone Deacetylase Inhibitors (2009) (547)
- Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. (1992) (542)
- Increased cortical kynurenate content in schizophrenia (2001) (540)
- Antidepressant Effect of Optogenetic Stimulation of the Medial Prefrontal Cortex (2010) (539)
- The hippocampal formation in schizophrenia. (2010) (512)
- Social stress induces neurovascular pathology promoting depression (2017) (493)
- ΔFosB in brain reward circuits mediates resilience to stress and antidepressant responses (2010) (457)
- Ketamine activates psychosis and alters limbic blood flow in schizophrenia (1995) (440)
- Sex-specific transcriptional signatures in human depression (2017) (427)
- Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers. (2016) (404)
- Schizophrenia and glutamatergic transmission. (1998) (393)
- Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. (2000) (376)
- Human postmortem tissue: What quality markers matter? (2006) (335)
- Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. (2013) (318)
- Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group. (1997) (310)
- Reduced activation and expression of ERK1/2 MAP kinase in the post‐mortem brain of depressed suicide subjects (2001) (301)
- Gender and schizophrenia. (1997) (295)
- Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. (2002) (267)
- Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). (2013) (266)
- A Role for Repressive Histone Methylation in Cocaine-Induced Vulnerability to Stress (2011) (252)
- Phenotype of schizophrenia: a review and formulation (2005) (251)
- Probing the human hippocampus using rCBF: Contrasts in schizophrenia (2001) (239)
- Differences in Resting-State Functional Magnetic Resonance Imaging Functional Network Connectivity Between Schizophrenia and Psychotic Bipolar Probands and Their Unaffected First-Degree Relatives (2012) (239)
- The initial field trials of DSM-5: new blooms and old thorns. (2013) (231)
- 2016 in Review. (2016) (222)
- Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. (1996) (222)
- Schizophrenic symptoms improve with apomorphine. (1978) (222)
- Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression (2013) (218)
- Critical Role of Histone Turnover in Neuronal Transcription and Plasticity (2015) (217)
- Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. (1998) (210)
- Is Aberrant Functional Connectivity A Psychosis Endophenotype? A Resting State Functional Magnetic Resonance Imaging Study (2013) (201)
- Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia (2014) (200)
- Schizophrenia: Scientific Progress (1989) (197)
- Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers. (2018) (193)
- Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. American Psychiatric Association. (1995) (190)
- Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors (2014) (184)
- A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: The Schizo-Bipolar Scale (2011) (182)
- Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. (2003) (174)
- β-catenin mediates behavioral resilience through Dicer1/microRNA regulation (2014) (167)
- Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. (2014) (166)
- AKT Signaling within the Ventral Tegmental Area Regulates Cellular and Behavioral Responses to Stressful Stimuli (2008) (165)
- Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. (2013) (164)
- Clozapine in tardive dyskinesia: observations from human and animal model studies. (1994) (163)
- A Novel Role of the WNT-Dishevelled-GSK3β Signaling Cascade in the Mouse Nucleus Accumbens in a Social Defeat Model of Depression (2011) (161)
- Patient response and resource management: another view of clozapine treatment of schizophrenia. (1995) (161)
- Insight and frontal cortical function in schizophrenia: A review (2006) (153)
- Long‐term Psychiatric Outcomes Following Traumatic Brain Injury: A Review of the Literature (2009) (151)
- The neurobiology of cognition in schizophrenia. (2006) (150)
- Strong inference, theory testing, and the neuroanatomy of schizophrenia. (1993) (148)
- The role of negative symptoms and cognitive dysfunction in schizophrenia outcome (1998) (145)
- Sequential Regional Cerebral Blood Flow Brain Scans Using PET with H215O Demonstrate Ketamine Actions in CNS Dynamically (2001) (144)
- Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy. (1990) (143)
- Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). (2013) (142)
- Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human. (1991) (141)
- Genetics and intermediate phenotypes of the schizophrenia—bipolar disorder boundary (2010) (139)
- Bipolar and schizophrenia network for intermediate phenotypes: outcomes across the psychosis continuum. (2014) (135)
- Partial dopamine agonists in the treatment of psychosis (2002) (134)
- Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. (2005) (133)
- Molecular adaptations of the blood–brain barrier promote stress resilience vs. depression (2020) (132)
- Correlations Between rCBF and Symptoms in Two Independent Cohorts of Drug-Free Patients with Schizophrenia (2006) (132)
- Functional effects of antipsychotic drugs: comparing clozapine with haloperidol (2003) (126)
- Glutamatergic aspects of schizophrenia (1999) (123)
- Reversal of Depressed Behaviors in Mice by p11 Gene Therapy in the Nucleus Accumbens (2010) (122)
- Improvement in tardive dyskinesia after muscimol therapy. (1979) (120)
- Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis. (2002) (117)
- Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes (2017) (114)
- Muscimol: GABA agonist therapy in schizophrenia. (1978) (113)
- D2-Family receptor distribution in human postmortem tissue: an autoradiographic study (1995) (111)
- Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response (1999) (111)
- Resting-state brain function in schizophrenia and psychotic bipolar probands and their first-degree relatives (2014) (110)
- Glutamate dysfunction in hippocampus: relevance of dentate gyrus and CA3 signaling. (2012) (110)
- Are structural brain abnormalities associated with suicidal behavior in patients with psychotic disorders? (2013) (106)
- Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia (1988) (106)
- Striatal enlargement in rats chronically treated with neuroleptic (1998) (104)
- Effects of Noncompetitive NMDA Receptor Blockade on Anterior Cingulate Cerebral Blood Flow in Volunteers with Schizophrenia (2005) (104)
- Time to clozapine response in a standardized trial. (1997) (103)
- Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia (2009) (102)
- Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. (2001) (102)
- Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. (2012) (100)
- Increased saccadic distractibility in tardive dyskinesia: Functional evidence for subcortical GABA dysfunction (1989) (100)
- Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia (1998) (99)
- The limbic cortex in schizophrenia: focus on the anterior cingulate (2000) (96)
- Brain activity in adolescent major depressive disorder before and after fluoxetine treatment. (2012) (96)
- Postsynaptic supersensitivity in schizophrenia. (1977) (95)
- Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study (1998) (95)
- Transdiagnostic Associations Between Functional Brain Network Integrity and Cognition (2017) (95)
- Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment. (1987) (94)
- Correlations between brain structure and symptom dimensions of psychosis in schizophrenia, schizoaffective, and psychotic bipolar I disorders. (2015) (94)
- Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action? (2009) (93)
- Placebo-controlled study of the D4/5-HT2A antagonist fananserin in the treatment of schizophrenia. (1999) (92)
- Developing novel treatments for mood disorders: accelerating discovery (2002) (92)
- Resting State Electroencephalogram Oscillatory Abnormalities in Schizophrenia and Psychotic Bipolar Patients and Their Relatives from the Bipolar and Schizophrenia Network on Intermediate Phenotypes Study (2014) (92)
- Phenomenological Psychopathology and Schizophrenia: Contemporary Approaches and Misunderstandings (2011) (92)
- Regional alterations in RGS4 protein in schizophrenia (2006) (91)
- Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar I disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer). (2015) (90)
- Fluoxetine Epigenetically Alters the CaMKIIα Promoter in Nucleus Accumbens to Regulate ΔFosB Binding and Antidepressant Effects (2014) (90)
- Frequency-Specific Neural Signatures of Spontaneous Low-Frequency Resting State Fluctuations in Psychosis: Evidence From Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Consortium. (2015) (89)
- Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy. (1982) (89)
- 2017 in Review. (2017) (89)
- Oculomotor abnormalities and their clinical correlates in schizophrenia. (1989) (88)
- Ultrastructural correlates of haloperidol‐induced oral dyskinesias in rat striatum (1995) (88)
- Alzheimer's disease (1987) (88)
- VGF function in depression and antidepressant efficacy (2017) (87)
- Effects of dopamine agonists in tardive dyskinesia. (1977) (86)
- Loss of pattern separation performance in schizophrenia suggests dentate gyrus dysfunction (2014) (86)
- Identifying dynamic functional connectivity biomarkers using GIG‐ICA: Application to schizophrenia, schizoaffective disorder, and psychotic bipolar disorder (2017) (84)
- Induction of Activating Transcription Factors (ATFs) ATF2, ATF3, and ATF4 in the Nucleus Accumbens and Their Regulation of Emotional Behavior (2008) (84)
- 2018 in Review. (2018) (84)
- White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study (2019) (83)
- Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. (2014) (82)
- Cholinergic influences in tardive dyskinesia. (1977) (81)
- Clozapine but not Haloperidol Re-establishes Normal Task-Activated rCBF Patterns in Schizophrenia within the Anterior Cingulate Cortex (2004) (81)
- Serum Response Factor Promotes Resilience to Chronic Social Stress through the Induction of ΔFosB (2010) (80)
- Schizophrenia: moving beyond monoamine antagonists. (2008) (80)
- [(3)H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims. (2002) (79)
- Transdiagnostic dimensions of psychosis in the Bipolar‐Schizophrenia Network on Intermediate Phenotypes (B‐SNIP) (2019) (79)
- Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories. (2014) (78)
- Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia. (1996) (78)
- A neuroendocrine study of supersensitivity in tardive dyskinesia. (1977) (77)
- Differential olanzapine plasma concentrations by sex in a fixed-dose study (1999) (77)
- Ketamine Effects on Eye Movements (2000) (76)
- Regional expression of RGS4 mRNA in human brain † (2004) (75)
- The GABAB receptor as a target for antidepressant drug action (2011) (75)
- Protein kinase C in the postmortem brain of teenage suicide victims (1997) (75)
- Emotion recognition deficits in schizophrenia-spectrum disorders and psychotic bipolar disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study (2014) (74)
- Prefrontal brain network connectivity indicates degree of both schizophrenia risk and cognitive dysfunction. (2013) (74)
- Sex-Specific Role for the Long Non-coding RNA LINC00473 in Depression (2020) (73)
- Conserved Higher-Order Chromatin Regulates NMDA Receptor Gene Expression and Cognition (2014) (73)
- Cerebral blood flow relationships associated with a difficult tone recognition task in trained normal volunteers. (1998) (73)
- Pathological gambling: focusing on the addiction, not the activity. (2006) (73)
- Glutamate pharmacology and the treatment of schizophrenia: current status and future directions (1995) (72)
- Neurobiological underpinnings of insight deficits in schizophrenia (2007) (71)
- Alterations in hippocampal connectivity across the psychosis dimension (2015) (71)
- ACF chromatin remodeling complex mediates stress–induced depressive–like behavior (2015) (70)
- Reimagining psychoses: An agnostic approach to diagnosis (2013) (70)
- Local Gyrification Index in Probands with Psychotic Disorders and Their First-Degree Relatives (2014) (69)
- The Effect of Chronic Haloperidol Treatment on Dendritic Spines in the Rat Striatum (1997) (68)
- Divalproex ER Combined with Olanzapine or Risperidone for Treatment of Acute Exacerbations of Schizophrenia (2009) (68)
- The efficacy of high-dose olanzapine versus clozapine in treatment-resistant schizophrenia: a double-blind crossover study. (2003) (68)
- Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia (2005) (67)
- Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and “well state” bipolar patients (1983) (67)
- Delayed regional metabolic actions of phencyclidine. (1993) (67)
- Regulator of G protein signaling 4 is a crucial modulator of antidepressant drug action in depression and neuropathic pain models (2013) (67)
- Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia (2014) (66)
- Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia. (2015) (66)
- Event-Related Potential and Time-Frequency Endophenotypes for Schizophrenia and Psychotic Bipolar Disorder (2015) (66)
- Cognitive burden of anticholinergic medications in psychotic disorders (2017) (66)
- Phencyclidine (PCP) and dizocilpine (MK801) exert time‐dependent effects on the expression of immediate early genes in rat brain (1998) (66)
- DEPRESSION ASSOCIATED WITH ORAL CHOLINE (1976) (65)
- Dopamine agonist treatment of schizophrenia with N-propylnorapomorphine. (1986) (64)
- Schizophrenia: treatment targets beyond monoamine systems. (2011) (62)
- Basal Ganglia GABAA and Dopamine D1 Binding Site Correlates of Haloperidol-Induced Oral Dyskinesias in Rat (1994) (62)
- Effect of dopamine system activation on substantia nigra pars reticulata output neurons: variable single-unit responses in normal rats and inhibition in 6-hydroxydopamine-lesioned rats (1984) (61)
- Kv3.1-containing K+ channels are reduced in untreated schizophrenia and normalized with antipsychotic drugs (2014) (61)
- Neural Activations During Auditory Oddball Processing Discriminating Schizophrenia and Psychotic Bipolar Disorder (2012) (60)
- Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. (2000) (60)
- Amygdala Hyperactivity at Rest in Paranoid Individuals With Schizophrenia. (2015) (60)
- ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial (2016) (59)
- mRNA and Protein Expression of Selective Alpha Subunits of G Proteins are Abnormal in Prefrontal Cortex of Suicide Victims (2002) (59)
- Effects of lithium on cortical thickness and hippocampal subfield volumes in psychotic bipolar disorder. (2015) (59)
- Evaluating Glutamatergic Transmission in Schizophrenia (2003) (58)
- Measurement and treatment research to improve cognition in schizophrenia: neuropharmacological aspects (2004) (58)
- Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia. (2002) (58)
- Tone discrimination performance in schizophrenic patients and normal volunteers: impact of stimulus presentation levels and frequency differences (1995) (58)
- Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders. (2016) (57)
- An important role for Cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors (2013) (57)
- Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains (2005) (56)
- Phosphorylation of the tubulin‐binding protein, stathmin, by Cdk5 and MAP kinases in the brain (2006) (55)
- Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder. (2007) (55)
- Strategies for Advancing Disease Definition Using Biomarkers and Genetics: The Bipolar and Schizophrenia Network for Intermediate Phenotypes. (2017) (54)
- Cognitive endophenotypes of psychosis within dimension and diagnosis (2012) (54)
- Stimulation of Prolactin and Growth Hormone Secretion by Muscimol, a γ-Aminobutyric Acid Agonist (1978) (53)
- Functional Connectivity of Brain Structures Correlates with Treatment Outcome in Major Depressive Disorder (2011) (53)
- Brain gray matter phenotypes across the psychosis dimension (2012) (53)
- Behavioral response inhibition in psychotic disorders: Diagnostic specificity, familiality and relation to generalized cognitive deficit (2014) (52)
- Deficits in Syntaxin 1 Phosphorylation in Schizophrenia Prefrontal Cortex (2010) (52)
- Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia‐thalamocortical neural pathways (2001) (52)
- PCP‐induced alterations in cerebral glucose utilization in rat brain: Blockade by metaphit, a PCP‐receptor‐acylating agent (1987) (50)
- Des-tyrosine-γ-endorphin administration in chronic schizophrenics. A preliminary report (1981) (50)
- Association of Choroid Plexus Enlargement With Cognitive, Inflammatory, and Structural Phenotypes Across the Psychosis Spectrum. (2019) (50)
- The Maryland Psychiatric Research Center scale and the characterization of involuntary movements (1997) (50)
- Hippocampal function, declarative memory, and schizophrenia: Anatomic and functional neuroimaging considerations (2005) (50)
- Frontal cortex function. (2004) (49)
- Abnormal smooth pursuit eye movements in schizophrenic patients are associated with cerebral glucose metabolism in oculomotor regions (1995) (49)
- Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects (1997) (49)
- Positron emission tomographic studies of regional cerebral glucose metabolism in idiopathic dystonia. (1988) (48)
- Spatiotemporal and frequency domain analysis of auditory paired stimuli processing in schizophrenia and bipolar disorder with psychosis. (2012) (48)
- Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study (2015) (48)
- Entorhinal cortex in temporal lobe epilepsy. (1995) (48)
- Multivariate Relationships Between Peripheral Inflammatory Marker Subtypes and Cognitive and Brain Structural Measures in Psychosis (2020) (47)
- Images in neuroscience (2004) (47)
- Muscarinic Agonists for the Treatment of Cognition in Schizophrenia (2008) (47)
- The relationship between affective state and the rhythmicity of activity in bipolar disorder. (2014) (47)
- Adverse Effects and Laboratory Parameters of High-Dose Olanzapine vs. Clozapine in Treatment-Resistant Schizophrenia (2003) (46)
- Efficacy and Safety of Lumateperone for Treatment of Schizophrenia (2020) (46)
- D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects. (1996) (46)
- Serotonin and schizophrenia. (1998) (46)
- The neurobiology of cognition in schizophrenia. (2006) (45)
- Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease (1986) (45)
- Long-term outcome of patients who receive ketamine during research (2001) (44)
- GABA-agonist therapy for Alzheimer's disease. (1986) (44)
- Epigenetic regulation of synaptic remodeling in stress disorders (2013) (44)
- Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C beta1 protein in the prefrontal cortex of teenage suicide subjects. (1999) (44)
- Social memory in mice: Disruption with an NMDA antagonist and attenuation with antipsychotic drugs (2009) (43)
- Racial disparities in bipolar disorder treatment and research: a call to action (2018) (43)
- GABA AGONIST TREATMENT IMPROVES TARDIVE DYSKINESIA (1983) (42)
- Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats. (1992) (42)
- Lysine vasopressin in Alzheimer disease (1982) (42)
- Neurobiology of self-awareness in schizophrenia: An fMRI study (2012) (42)
- Neuroplasticity and schizophrenia (2004) (42)
- Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls (2018) (42)
- Deconstructing psychosis. (2007) (41)
- Cell type-specific epigenetic links to schizophrenia risk in the brain (2019) (41)
- 2015 in Review. (2015) (41)
- Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety (1997) (40)
- Neural complexity as a potential translational biomarker for psychosis. (2017) (39)
- Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia (1998) (38)
- Smooth pursuit eye movement, prepulse inhibition, and auditory paired stimuli processing endophenotypes across the schizophrenia-bipolar disorder psychosis dimension. (2014) (38)
- Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression. (2003) (38)
- Treating impaired cognition in schizophrenia. (2012) (37)
- Does Biology Transcend the Symptom-based Boundaries of Psychosis? (2016) (37)
- Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophrenia (2009) (37)
- Diverse Non-genetic, Allele-Specific Expression Effects Shape Genetic Architecture at the Cellular Level in the Mammalian Brain (2017) (36)
- THIP treatment of Huntington's disease (1983) (36)
- Impulsivity across the psychosis spectrum: Correlates of cortical volume, suicidal history, and social and global function (2016) (36)
- Comparison of objective and subjective assessments of sleep time in subjects with bipolar disorder. (2013) (36)
- Dr. Pandey and Associates Reply (1977) (36)
- Sleep polygraphy in schizophrenia: Methodological issues (1990) (35)
- Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptors. (1984) (35)
- Regression dynamic causal modeling for resting‐state fMRI (2020) (34)
- Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives (2016) (34)
- Aberrant H3.3 dynamics in NAc promote vulnerability to depressive-like behavior (2016) (34)
- Learning and Generalization in Schizophrenia: Effects of Disease and Antipsychotic Drug Treatment (2010) (34)
- Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design (1993) (33)
- [3H]Neurotensin receptor densities in human postmortem brain tissue obtained from normal and schizophrenic persons. An autoradiographic study (1998) (33)
- Dr. Tamminga and Associates Reply (1978) (33)
- Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia (1998) (33)
- VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine (2018) (32)
- In vivo detection of serine in the human brain by proton magnetic resonance spectroscopy (1H‐MRS) at 7 Tesla (2009) (32)
- NMDA-Sensitive Glutamate Antagonism: A Human Model for Psychosis (1999) (32)
- Auditory steady-state EEG response across the schizo-bipolar spectrum (2019) (32)
- Chronic Olanzapine or Sertindole Treatment Results in Reduced Oral Chewing Movements in Rats Compared to Haloperidol (1998) (32)
- Absence of ketamine effects on memory and other cognitive functions in schizophrenia patients. (1996) (31)
- Hippocampal Volume in Healthy Controls Given 3-Day Stress Doses of Hydrocortisone (2015) (31)
- The interactive effects of ketamine and nicotine on human cerebral blood flow (2010) (30)
- Psychiatric morbidity in research volunteers. (1990) (30)
- Huntington's disease (1986) (30)
- Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders (2015) (30)
- The promise of new drugs for schizophrenia treatment. (1997) (29)
- Diagnostic specificity and familiality of early versus late evoked potentials to auditory paired stimuli across the schizophrenia-bipolar psychosis spectrum. (2014) (29)
- Schizophrenia: new phenes and new genes. (1999) (29)
- Novel transcriptional networks regulated by CLOCK in human neurons (2017) (29)
- Callosal Abnormalities Across the Psychosis Dimension: Bipolar Schizophrenia Network on Intermediate Phenotypes (2016) (29)
- Multivariate genetic determinants of EEG oscillations in schizophrenia and psychotic bipolar disorder from the BSNIP study (2015) (29)
- The Wechsler ACS Social Perception Subtest (2012) (29)
- Welcome (2018) (28)
- Accelerated evolution of oligodendrocytes in the human brain (2019) (28)
- Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder (2016) (28)
- Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use. (2016) (28)
- Testing Psychosis Phenotypes From Bipolar-Schizophrenia Network for Intermediate Phenotypes for Clinical Application: Biotype Characteristics and Targets. (2020) (28)
- The new generation of antipsychotic drugs (1996) (28)
- Alterations in sleep polygraphy after neuroleptic withdrawal: A putative supersensitive dopaminergic mechanism (1989) (27)
- Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man (2004) (27)
- The Promise of New Drugs for Schizophrenia Treatment (1997) (27)
- Hippocampal novelty activations in schizophrenia: Disease and medication effects (2012) (27)
- The neuropharmacology of psychosis. (2007) (27)
- Risk factors for schizophrenia. Follow-up data from the Northern Finland 1966 Birth Cohort Study. (2006) (27)
- Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1 (2017) (27)
- Negative Symptoms: A Critique of Current Approaches (1991) (26)
- An increase in NMDA-sensitive [3H]glutamate and [3H]kainate binding in hippocampus 24 hours after PCP (1994) (26)
- Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia. (2019) (26)
- Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches (2020) (26)
- CHOLECYSTOKININ: POTENTIAL PEPTIDERGIC ANTIPSYCHOTIC (1984) (26)
- Examining Functional Resting-State Connectivity in Psychosis and Its Subgroups in the Bipolar-Schizophrenia Network on Intermediate Phenotypes Cohort. (2016) (26)
- CCK26–33 Degrading Activity in Brain and Nonneural Tissue: A Metalloendopeptidase (1985) (25)
- Reduced brain somatostatin levels in Alzheimer's disease. (1985) (25)
- Vasopressin studies in Alzheimer's disease (1982) (25)
- Sex differences in associations of arginine vasopressin and oxytocin with resting‐state functional brain connectivity (2017) (25)
- Brain gray matter network organization in psychotic disorders (2019) (25)
- Bromocriptine and CF 25-397 in the treatment of tardive dyskinesia. (1980) (24)
- Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study (2017) (23)
- 2011 in Review (2011) (23)
- Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment (2015) (23)
- Pharmacologic properties of (−)-3PPP (preclamol) in man (2005) (23)
- Cooperative synaptic and intrinsic plasticity in a disynaptic limbic circuit drive stress-induced anhedonia and passive coping in mice (2020) (23)
- Retinal layer abnormalities and their association with clinical and brain measures in psychotic disorders: A preliminary study (2020) (23)
- Saccadic distractibility in schizophrenic patients with tardive dyskinesia. (1989) (23)
- Dopamine Neuronal Tracts in Schizophrenia: Their Pharmacology and in Vivo Glucose Metabolism (1988) (23)
- Schizophrenia: Evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiology (2015) (22)
- Cholecystokinin and neurotensin gradients in human CSF. (1985) (22)
- 2012 in review. (2012) (22)
- Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives. (2016) (22)
- PET‐FDG Test‐Retest Reliability During a Visual Discrimination Task in Schizophrenia (1993) (22)
- Large-Scale Fusion of Gray Matter and Resting-State Functional MRI Reveals Common and Distinct Biological Markers across the Psychosis Spectrum in the B-SNIP Cohort (2015) (22)
- 2014 in review. (2014) (22)
- Sertindole (Serdolect): preclinical and clinical findings of a new atypical antipsychotic. (1997) (22)
- Effect of apomorphine on schizophrenic symptoms (1977) (22)
- Stimulating and inhibitory effects of the dopamine “stabilizer” (−)-OSU6162 on dopamine D2 receptor function in vitro (2007) (22)
- Genetic Sources of Subcomponents of Event-Related Potential in the Dimension of Psychosis Analyzed From the B-SNIP Study. (2015) (21)
- Cell type-specific epigenetic links to schizophrenia risk in the brain (2019) (21)
- An investigation of reasoning by analogy in schizophrenia and autism spectrum disorder (2014) (21)
- Practical treatment information for schizophrenia. (2006) (21)
- GABA agonist-induced changes in motor, oculomotor, and attention measures correlate in schizophrenics with tardive dyskinesia (1992) (21)
- Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48‐hour time course (1996) (20)
- GABA system: clinical research and treatment of tardive dyskinesia. (1983) (20)
- Tolerance to the anti-avoidance properties of cholecystokinin-octapeptide (1983) (20)
- Multivariate Relationships Between Cognition and Brain Anatomy Across the Psychosis Spectrum. (2018) (20)
- Deviation from expected cognitive ability across psychotic disorders (2017) (20)
- Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium (2021) (20)
- GWAS Significance Thresholds for Deep Phenotyping Studies Can Depend Upon Minor Allele Frequencies and Sample Size (2020) (19)
- Machine learning improved classification of psychoses using clinical and biological stratification: Update from the bipolar-schizophrenia network for intermediate phenotypes (B-SNIP) (2019) (19)
- 2013 in review. (2013) (19)
- ΔFosB Induction in Prefrontal Cortex by Antipsychotic Drugs is Associated with Negative Behavioral Outcomes (2014) (19)
- Neural correlates of successful response inhibition in unmedicated patients with late-life depression. (2012) (19)
- Low dose raclopride spares the extrapyramidal system in rat brain from metabolic effects. (1993) (19)
- Reduced GluN1 in mouse dentate gyrus is associated with CA3 hyperactivity and psychosis-like behaviors (2018) (18)
- MRI assessment of cerebral oxygen metabolism in cocaine‐addicted individuals: hypoactivity and dose dependence (2014) (18)
- Purification of Solid-Phase Synthesized Peptides on the Coil Planet Centrifuge (1984) (18)
- Brain imaging demonstrates a reduced neural impact of eating in obesity (2016) (18)
- Measurement of glycine in gray and white matter in the human brain in vivo by 1H MRS at 7.0 T (2012) (18)
- Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients (1992) (18)
- The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration (2005) (18)
- Products of cholecystokinin (CCK)-octapeptide proteolysis interact with central CCK receptors (1985) (18)
- The costs of drugs for schizophrenia. (2006) (17)
- Machine learning reveals bilateral distribution of somatic L1 insertions in human neurons and glia (2019) (17)
- Accelerating new knowledge in schizophrenia. (2008) (17)
- Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease. (1983) (17)
- Molecular alterations in the medial temporal lobe in schizophrenia (2020) (17)
- Hippocampal subfield transcriptome analysis in schizophrenia psychosis (2020) (16)
- Affinities and intrinsic activities of dopamine receptor agonists for the hD21 and hD4.4 receptors. (1996) (16)
- Why neuroleptic withdrawal in schizophrenia? (1995) (16)
- Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease (1983) (16)
- Deconstructing Psychosis: Refining the Research Agenda for Dsm-v (2009) (16)
- Similarities and differences among antipsychotics. (2003) (16)
- The Science of Antipsychotics: Mechanistic Insight (2003) (16)
- Family history of psychosis moderates early auditory cortical response abnormalities in non‐psychotic bipolar disorder (2013) (16)
- Psychosis is Emerging as a Learning and Memory Disorder (2013) (16)
- International Congress on Schizophrenia Research (2003) (15)
- GABA neurons in the human prefrontal cortex. (2004) (15)
- Conflict of interest-- an issue for every psychiatrist. (2009) (15)
- Effects of systemically administered cholecystokinin-octapeptide on local cerebral metabolism. (1984) (15)
- 126 CLINICAL COURSE AND CELLULAR PATHOLOGY OF TARDIVE DYSKINESIA (2002) (15)
- Subtyping Schizophrenia Patients Based on Patterns of Structural Brain Alterations. (2021) (15)
- Efficacy and safety of sertindole in a trial of schizophrenic patients (1995) (15)
- Effect of neuroleptic withdrawal on plasma prolactin: A possible marker of receptor adaptation (1989) (15)
- Current problems with the pharmacotherapy of schizophrenia (1995) (15)
- Pharmacologic studies of tardive dyskinesia. (1980) (15)
- Failure of single-dose lecithin to alter aspects of central cholinergic activity in Alzheimer's disease. (1983) (15)
- Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study. (2015) (14)
- An epigenomics approach to individual differences and its translation to neuropsychiatric conditions (2016) (14)
- Chromatin domain alterations linked to 3D genome organization in a large cohort of schizophrenia and bipolar disorder brains (2022) (14)
- CSF somatostatin immunoreactivity and GH plasma levels in Alzheimer's disease (1984) (14)
- Endophenotypes, Epigenetics, Polygenicity and More: Irv Gottesman’s Dynamic Legacy (2017) (14)
- Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats (2000) (14)
- Olanzapine (Zyprexa):characteristics of a new antipsychotic. (1997) (14)
- Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide. (1987) (13)
- Predictive Pursuit Association with Deficits in Working Memory in Psychosis (2012) (13)
- Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders (2021) (13)
- Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder (2020) (13)
- NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis (2019) (13)
- Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia—a multicenter harmonized diffusion tensor imaging study (2021) (13)
- Associations between adolescent cannabis use and brain structure in psychosis (2018) (13)
- Memory generalization is selectively altered in the psychosis dimension (2012) (13)
- Schizophrenia in a molecular age (1999) (13)
- Using Biomarker Batteries (2015) (13)
- Alterations in intrinsic fronto‐thalamo‐parietal connectivity are associated with cognitive control deficits in psychotic disorders (2018) (13)
- MK801 induces late regional increases in NMDA and kainate receptor binding in rat brain (1995) (12)
- Intrinsic neural activity differences among psychotic illnesses. (2017) (12)
- The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia (2020) (12)
- Insight and empathy in schizophrenia (2012) (12)
- Investigating Sexual Dimorphism of Human White Matter in a Harmonized, Multisite Diffusion Magnetic Resonance Imaging Study. (2020) (12)
- Multidose Risperidone Treatment Evaluated in a Rodent Model of Tardive Dyskinesia (2006) (12)
- Can a Framework Be Established for the Safe Use of Ketamine? (2018) (12)
- A randomized, placebo-controlled proof-of-concept, crossover trial of phenytoin for hydrocortisone-induced declarative memory changes. (2013) (12)
- GABA dysfunction in the pathophysiology of tardive dyskinesia. (1985) (12)
- Loss of the cortisol response to naltrexone in Alzheimer's disease (1988) (12)
- GABAmimetic treatments for tardive dyskinesia: efficacy and mechanism. (1989) (12)
- When is polypharmacy an advantage? (2011) (11)
- Pharmacologic relationship of antisaccade and dyskinesia in schizophrenic patients. (1993) (11)
- Tiagabine inhibits haloperidol-induced oral dyskinesias in rats (2005) (11)
- Cholecystokinin: a neuropeptide in the treatment of schizophrenia. (1986) (11)
- Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis (2020) (11)
- Biotyping in psychosis: using multiple computational approaches with one data set (2020) (11)
- 2009 in review. (2009) (11)
- Brain metabolism patterns are sensitive to attentional effort associated with a tone recognition task (1996) (11)
- Cholecystokinin octapeptide analogues stable to brain proteolysis (1985) (11)
- Subtle effects of ketamine on memory when administered following stimulus presentation (2005) (10)
- Distribution of dopamine D4 receptor in human postmortem brain sections: Autoradiographic studies with [3H]-NGD-94-1 (1996) (10)
- Smooth pursuit eye movement deficits as a biomarker for psychotic features in bipolar disorder—Findings from the PARDIP study (2019) (10)
- Animal models of schizophrenia emphasizing construct validity. (2012) (10)
- Differential responses in prolactin levels induced by naloxone in humans (1985) (10)
- Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini. (1984) (10)
- Changing concepts in the neurochemistry of schizophrenia. (2001) (10)
- Treatment mechanisms: traditional and new antipsychotic drugs (2000) (10)
- Conflict of interest, round 2. (2006) (10)
- Recent developments in the neuropharmacology of schizophrenia. (1995) (10)
- Differential patterns of glucose metabolism in deficit and non-deficit schizophrenia (1989) (10)
- Haloperidol kinetics and clinical response (1991) (10)
- New approaches in psychiatric drug development (2018) (10)
- Treatment-refractory schizophrenia (2004) (10)
- Electrophysiological correlates of emotional scene processing in bipolar disorder. (2019) (10)
- The association between mood state and chronobiological characteristics in bipolar I disorder: a naturalistic, variable cluster analysis-based study (2018) (10)
- Cortex, IV; Regional Cerebral Blood Flow (1995) (9)
- 7. Psychopathology and the question of neurodevelopmental or neurodegenerative disorder (1991) (9)
- Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B–SNIP) cohort (2019) (9)
- A comparison of peripheral and central effects of CCK8 on water-reinforced operant responding. (1985) (9)
- Genetic analysis of deep phenotyping projects in common disorders (2017) (9)
- Treatment of schizophrenia with ergot derivatives (1979) (9)
- Studies in schizophrenia: pathophysiology and treatment (2002) (9)
- Intrinsic neural activity differences in psychosis biotypes: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium. (2019) (9)
- Dopamine D-1 receptor agonist stimulation of prolactin secretion in man (1988) (9)
- Catching up on schizophrenia. The Fifth International Congress on Schizophrenia Research, Warm Springs, Va, April 8-12, 1995. (1996) (9)
- Reversibility and irreversibility of tardive dyskinesia following neuroleptic withdrawal (1992) (9)
- Joint Coupling of Awake EEG Frequency Activity and MRI Gray Matter Volumes in the Psychosis Dimension: A BSNIP Study (2015) (9)
- Cholinergic Mechanisms in Schizophrenia, Mania and Depression (1978) (9)
- Elevation of plasma prolactin concentrations by intravenous SCH 23390 and SKF 38393 in conscious rats. (1987) (9)
- Cholecystokinin‐mediated Synaptic Function and the Treatment of Neuropsychiatric Disease (1985) (9)
- COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia (2016) (8)
- Psychosis subgroups differ in intrinsic neural activity but not task-specific processing (2017) (8)
- Novel gene-brain structure relationships in psychotic disorder revealed using parallel independent component analyses (2017) (8)
- Improving the predictive potential of diffusion MRI in schizophrenia using normative models—Towards subject‐level classification (2021) (8)
- Gamma-Aminobutyric Acid (GABA) Pathways in Tardive Dyskinesia (1989) (8)
- Neural networks: neural systems vi: basal ganglia. (2001) (8)
- Minimized tolerance to the suppressive effects of CCK8 on operant responding. (1983) (8)
- Brief Report: Insight into Illness and Social Attributional Style in Asperger’s Syndrome (2012) (8)
- VEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study (2018) (8)
- The anatomy of fear extinction. (2006) (8)
- Prolonged hemodynamic response during incidental facial emotion processing in inter-episode bipolar I disorder (2014) (8)
- The endocrinology of extrapyramidal system disorders. (1988) (8)
- Normal smooth pursuit eye movements in volunteer subjects meeting schizotypal personality disorder criteria. (1991) (8)
- Chromatography of AC-ASP-TYR-MET-GLY-TRP-MET-ASP-NH2 on the Horizontal flow-Through Coil Planet Centrifuge and the High-Speed Multi-Layer Coil Planet Centrifuge (1984) (8)
- Parametric study of accuracy and response time in schizophrenic persons making visual or auditory discriminations (2004) (8)
- Accelerated evolution of oligodendrocytes in human brain (2019) (8)
- Chromatin profiling in human neurons reveals aberrant roles for histone acetylation and BET family proteins in schizophrenia (2022) (8)
- White matter microstructure across brain-based biotypes for psychosis – findings from the bipolar-schizophrenia network for intermediate phenotypes (2020) (8)
- Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study. (2016) (7)
- What can clozapine’s effect on neural oscillations tell us about its therapeutic effects? A scoping review and synthesis (2022) (7)
- Erratum: An important role for Cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors (Molecular Psychiatry (2013) DOI:10.1038/mp.2013.12) (2014) (7)
- Common variants of NRXN1, LRP1B and RORA are associated with increased ventricular volumes in psychosis - GWAS findings from the B-SNIP deep phenotyping study (2017) (7)
- Switch or Stay (2006) (7)
- The DSM‐III Diagnosis of Schizophrenic‐Like Illness and the Clinical: Pharmacology of Psychosis (1982) (7)
- Images in neuroscience. Cognition: procedural memory. (2000) (7)
- Approaching human neuroscience for disease understanding (2014) (7)
- Altered cerebral perfusion in bipolar disorder: A pCASL MRI study (2020) (7)
- Developments in Somatic Treatment Introduction. (2017) (7)
- Working Memory Remediation and the D1 Receptor (2009) (7)
- Stimulation of prolactin and growth hormone secretion by muscimol, a gamma-aminobutyric acid agonist. (1978) (7)
- Purification of a cholecystokinin fragment peptide in the horizontal flow-through coil planet centrifuge. (1984) (6)
- Des-tyrosine-gamma-endorphin administration in chronic schizophrenics. A preliminary report. (1981) (6)
- Autism BrainNet: A network of postmortem brain banks established to facilitate autism research. (2018) (6)
- Setting Measurement-Based Care in Motion: Practical Lessons in the Implementation and Integration of Measurement-Based Care in Psychiatry Clinical Practice (2021) (6)
- Molecular biology, V. Immediate early genes. (1997) (6)
- Gene expression correlates of the oscillatory signatures supporting human episodic memory encoding (2021) (6)
- Neurochemical and metabolic consequences of elevated cerebrospinal fluid quinolinic acid concentrations in rat brain (1997) (6)
- Assessing Striatal Dopamine in Schizophrenia (2022) (6)
- Partial Dopamine Agonists and the Treatment of Psychosis (2005) (6)
- ERGOT DERIVATIVES IN THE TREATMENT OF PSYCHOTIC AND HYPERKINETIC DISORDERS (1979) (6)
- Neuronal cholecystokinin and schizophrenia: pathogenic and therapeutic studies (1986) (6)
- Caerulein treatment of Parkinson's disease. (1985) (6)
- Effect Of amphetamine, α-Methyl-P-tyrosine (α-MPT) and antipsychotic agents on dopamine D2-type receptor occupancy in rats (1999) (6)
- Dopamine D2, D3, D4 receptors in human postmortem brain sections: Comparison between normals and schizophrenics (1996) (6)
- A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits (2022) (6)
- The biology of schizophrenia (2000) (6)
- Images in neuroscience. The hippocampus in epilepsy. (1995) (6)
- The endocrinology of extrapyramidal system disorders. (1988) (5)
- Rapid communication Stimulating and inhibitory effects of the dopamine ''stabilizer'' (2)-OSU6162 on dopamine D2 receptor function in vitro (2007) (5)
- Clinical action of remoxipride. (1994) (5)
- Clozapine conflict [6] (1996) (5)
- 53. 11C NMSP receptor occupancy by clozapine and haloperidol in schizophrenic subjects (1996) (5)
- A Diagnosis and Biotype Comparison Across the Psychosis Spectrum: Investigating Volume and Shape Amygdala-Hippocampal Differences from the B-SNIP Study. (2021) (5)
- Brain endopeptidase generates enkephalin from striatal precursors (1982) (5)
- Choosing among old and new antipsychotics. (1996) (5)
- Neuroendocrine Studies in Huntington’s Disease (1984) (5)
- Positron emission tomography evaluation of dopaminergic pathways (1995) (5)
- Schizophrenia, I. (2003) (5)
- Associating Psychotic Symptoms with Altered Brain Anatomy in Psychotic Disorders Using Multidimensional Item Response Theory Models. (2019) (5)
- Abnormal perfusion fluctuation and perfusion connectivity in bipolar disorder measured by dynamic arterial spin labeling (2020) (5)
- Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy (2021) (5)
- D2-family receptors in schizophrenia: Distribution and implications for treatment (1995) (5)
- GABAmimetic drugs in hyperkinetic involuntary movement disorders and their effects on mental status (1990) (5)
- Auditory paired-stimuli responses across the psychosis and bipolar spectrum and their relationship to clinical features (2020) (5)
- Neuroleptic-Induced Movement Disorders: GABAergic treatments for tardive dyskinesia (1996) (5)
- Effect of amphetamine, alpha-methyl-p-tyrosine (alpha-MPT) and antipsychotic agents on dopamine D2-type receptor occupancy in rats. (1999) (5)
- Resting state auditory-language cortex connectivity is associated with hallucinations in clinical and biological subtypes of psychotic disorders (2020) (5)
- Drug-induced oral dyskinesias in rats after traditional and new neuroleptics (2005) (4)
- Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features. (2021) (4)
- Correction: Corrigendum: Sex-specific transcriptional signatures in human depression (2018) (4)
- Domains of dysfunction in schizophrenia: implications for diagnosis (2008) (4)
- Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disorders (2022) (4)
- Regional and Sex-Specific Alterations in the Visual Cortex of Individuals With Psychosis Spectrum Disorders (2022) (4)
- Common Data Elements for National Institute of Mental Health-Funded Translational Early Psychosis Research. (2019) (4)
- Treatments for chronic psychosis (2001) (4)
- 331. Treatment of schizophrenia: New antidopaminergic strategies (1996) (4)
- The neuroanatomy of the deficit syndrome (1992) (4)
- Effects of genetic and environmental risk for schizophrenia on hippocampal activity and psychosis-like behavior in mice (2018) (4)
- Apomorphine reduces schizophrenic symptoms. (1980) (4)
- Three dimensional registration, display, and analysis of PET-MR images (1990) (4)
- NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) (2020) (4)
- Time course of rcbf changes after acute haloperidol in patients with schizophrenia (1998) (4)
- Remoxipride therapy in treatment resistant schizophrenia (1993) (4)
- P.671 Efficacy and safety of lumateperone tosylate 42mg in the treatment of schizophrenia: A pooled analysis of phase 2 and 3 studies (2019) (4)
- Failure of chronic haloperidol to affect prolactin secretion due to acute haloperidol administration. (1985) (4)
- Antipsychotic and antidyskinetic properties of ergot dopamine agonists. (1980) (4)
- Labile hypertension after antipsychotic drug withdrawal: A case report (1985) (4)
- 89 [3H]-NGD-94-I binding in human postmortem brain of normals and schizophrenics off-, or on-antipsychotic drugs at death (1997) (4)
- The application of neuroimaging techniques to drug development. (1997) (4)
- The Effects of Cholinergic Drugs on the Involuntary Movements of Tardive Dyskinesia (1980) (3)
- 248. Protein kinase A in the postmortem brain of suicide victims (2000) (3)
- Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study (2022) (3)
- 472 Blood flow activation differences during an auditory task in schizophrenic patients with and without primary negative symptoms (1997) (3)
- Dr. Zimbroff and Colleagues Reply (1998) (3)
- Higher genetic risk of schizophrenia is associated with lower cognitive performance in healthy individuals (2017) (3)
- Images in neuroscience (2002) (3)
- Making Sense of the Matrix: A Qualitative Assessment and Commentary on Connecting Psychiatric Symptom Scale Items to the Research Domain Criteria (RDoC). (2022) (3)
- Neural Processing of Repeated Emotional Scenes in Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder. (2021) (3)
- Brain development, XII: Maturation in brain activation (1999) (3)
- Central cholecystokinin octapeptide reduces glucose utilization in subcortical but not cortical rat brain. (1987) (3)
- Dopaminergic and glutamatergic influences in the systems biology of schizophrenia (2003) (3)
- TIME COURSE OF rCBF CHANGES AFTER ACUTE HALOPERIDOL IN PATIENTS WITH SCHIZOPHRENIA (1998) (3)
- Human brain receptors, VIII. The distribution of ionotropic glutamate receptors in the human hippocampus. (1994) (3)
- Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders (2021) (3)
- Anterior-posterior axis of hippocampal subfields across psychoses: A B-SNIP study (2021) (3)
- The deficit form of schizophrenia (1989) (3)
- Reduced White Matter Microstructure in Bipolar Disorder with and without Psychosis. (2021) (3)
- The prevention and management of tardive dyskinesia in the elderly (2002) (3)
- Department of Psychiatry and Behavioral Sciences Grand Rounds (2020) (3)
- Effects of Apomorphine and Amphetamine on Tardive Dyskinesia (1980) (3)
- The Human Genome Sequence (2001) (3)
- Novel antidopaminergic strategies for the treatment of schizophrenia (1995) (3)
- S-2-2 The development of (−)-3PPP as an Antipsychotic drug (1996) (3)
- Neuroleptic Treatment of Schizophrenic Patients: How Do Haloperidol and Clozapine Normalize Brain Blood Flow Patterns Associated with a Difficult Tone Recognition Task? (1999) (3)
- 393 Effecf of neuroleptic treatment on post-mortem rodent striatal volumes (1997) (3)
- Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens (Science Translational Medicine (2010) 2, (55er3)) (2010) (3)
- 536 Olanzapine VS. chlorpromazine in therapy-refractory schizophrenia (1997) (3)
- Do neurobiological differences exist between paranoid and non-paranoid schizophrenia? Findings from the bipolar schizophrenia network on intermediate phenotypes study (2020) (3)
- Photophobic and photomanic behavior in psychoses (1990) (3)
- DOPAMINE AGONIST TREATMENT OF SCHIZOPHRENIA (1979) (3)
- Images in neuroscience. Cortical GABA-ergic interneurons. (1994) (3)
- 87. Social Stress Induces Neurovascular Pathology Promoting Immune Infiltration and Depression (2018) (3)
- Biological fingerprints for psychosis (2019) (3)
- The human genome: microarray expression analysis. (2001) (3)
- Switch or stay? (2006) (3)
- A mouse knockout (1996) (3)
- 461 How many subjects? A monte carlo bootstrap simulation for functional imaging (1997) (2)
- Brain Development, X (1999) (2)
- Human brain receptors, IX: Benzodiazepine-GABA(A) ionotropic receptors (1994) (2)
- Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders (2021) (2)
- Human brain receptors. Electron micrograph of human striatum showing synaptic structures. (1994) (2)
- Editorial: Dopaminergic Alterations in Schizophrenia (2021) (2)
- Using Brain-Based Phenotyping to Improve Discovery in Psychiatry. (2018) (2)
- Neuroscience and schizophrenia. (1999) (2)
- Time course of RCBF changes with haloperidol and olanzapine over a six week treatment period (2003) (2)
- Schizophrenia neuroanatomy and theory falsification (1991) (2)
- Schizophrenia research: a biennium of progress. Proceedings from the Sixth International Congress on Schizophrenia Research. Colorado Springs, CO, April 12-16, 1997. (1998) (2)
- Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): protocol for identification of novel biomarkers via neurophysiology (2021) (2)
- Acetylated Chromatin Domains Link Chromosomal Organization to Cell- and Circuit-level Dysfunction in Schizophrenia and Bipolar Disorder (2021) (2)
- No connectivity alterations for striatum, default mode, or salience network in association with self-reported antipsychotic medication dose in a large chronic patient group (2020) (2)
- Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP Study (2021) (2)
- 185 The Safety and Tolerability of Lumateperone 42 mg for the Treatment of Schizophrenia: A Pooled Analysis of 3 Randomized Placebo-Controlled Trials (2020) (2)
- Posing Hypotheses Responsibly in Psychiatry (2011) (2)
- An opportunity for primary prevention research in psychotic disorders (2021) (2)
- Human brain receptors, IV. Human in vivo receptor imaging. (1994) (2)
- Desmosterol and 7-dehydrocholesterol concentrations in post mortem brains of depressed people: The role of trazodone (2022) (2)
- Increased growth hormone response to clonidine in 6-hydroxydopamine-treated rats (2004) (2)
- Phenomenology and Clinical Science of Schizophrenia (2007) (2)
- 198 Blockade of phencyclidine- and MK801-induced regional zif268 mRNA expression (1997) (2)
- Comprar Deconstructing Psychosis. Refining the Research Agenda for DSM-V | Carol A. Tamminga | 9780890426531 | American Psychiatric Publishing (2010) (2)
- GABAmimetics: a new class of antidepressant agents? (1990) (2)
- P-9-1 Differing properties of dopamine agonists and partial agonists at the cloned human D21 and D4.4 receptors (1996) (2)
- Increased 5HT2A Receptors and Impaired Phosphoinositide Signaling in the Postmortem Brain of Suicide Victims (2001) (2)
- Validity of the deficit syndrome (1991) (2)
- rCBF pattern differences between medication-free schizophrenic patients with and without deficit symptoms (1996) (2)
- P-7-14 Efficacy and safety of three doses of sertindole and haldol in schizophrenic patients (1996) (2)
- 92 Post-mortem determination of kynurenine and kynurenic acid levels in the brains of schizophrenic patients (1997) (2)
- Images in neuroscience. Cortex, V. Prefrontal leukotomy. (1995) (2)
- Images in neuroscience. Cortex, VI. Auditory cortical function. (1995) (2)
- Can NMDA antagonists help us understand the psychosis mechanism in schizophrenia? (1993) (2)
- Using psychosis biotypes and the Framingham model for parsing psychosis biology (2022) (2)
- Brain Development, V: Experience Affects Brain Development (1998) (2)
- Images in Neuroscience: Brain Development, I: The Neural Plate (1998) (2)
- Principles of the Pharmacotherapy of Schizophrenia (2011) (2)
- Antisaccade error rates and gap effects in psychosis syndromes from bipolar-schizophrenia network for intermediate phenotypes 2 (B-SNIP2) (2021) (2)
- Apomorphine's antipsychotic activity. (1985) (2)
- The hippocampus. (2005) (2)
- Dopamine D4 receptors in human postmortem brain tissue of normal and schizophrenic subjects. An [3]NGD-94-1 study (1998) (2)
- Schizophrenia research: a progress report, summarizing proceedings of the 1999 International Congress on Schizophrenia Research. (2000) (2)
- Conflict of interest. (2006) (2)
- Perfusion Deficit in Schizophrenia and Correlation with Psychopathological Symptoms (2009) (2)
- Clozapine conflict. (1996) (2)
- Erratum: mRNA and Protein Expression of Selective Alpha Subunits of G Proteins are Abnormal in Prefrontal Cortex of Suicide Victims⋆ (2002) (1)
- D2 receptor occupancy with clozapine vs haloperidol in schizophrenia by 11C-NMSP pet (1993) (1)
- Cavum septum pellucidum (CSP) in treatment resistant schizophrenia (1995) (1)
- Human brain receptors, VI: Ionotropic receptors (1994) (1)
- Treating Schizophrenia Now and Developing Strategies for the Next Decade (2001) (1)
- Contamination-free measurement of GABA in the human brain by optimized PRESS at 7 . 0 T in vivo (2011) (1)
- Response time versus brain blood flow correlation patterns in a low error, sensory motor task: Normal volunteers vs patients with schizophrenia (2000) (1)
- F168. Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia (2019) (1)
- Sertindole, a new antipsychotic drug (1997) (1)
- Cortex, XI. Amyloid plaques. (1995) (1)
- Human brain receptors,V. Binding and message. (1994) (1)
- GABA hypothesis of tardive dyskinesia: clinical neurochemistry and neurophysiology (1989) (1)
- Cholecystokinin Octapeptide's Effect on Local Cerebral Glucose Utilization in the Laboratory Rat (1985) (1)
- Frontal and thalamic hypometabolism in schizophrenia (2003) (1)
- Relationship of butaperazine blood levels to plasma prolactin in chronic schizophrenic patients (1979) (1)
- Long-term psychiatric outcomes following traumatic brain injury: A review of the literature: (717682011-015) (2010) (1)
- γ-Type Endorphins and Schizophrenia-Reply (1981) (1)
- Muscimol therapy of hyperkinetic extpapyramidal disorders Thomas (1979) (1)
- The factor structure for psychotic symptoms in patients with schizophrenia over three clinical states (1998) (1)
- Characterization of the extracellular free water signal in schizophrenia using multi-site diffusion MRI harmonization. (2023) (1)
- Benzodiazeprine receptors in human postmortem brain: Effect of schizophrenia, suicide, and neuroleptic drug treatment (1995) (1)
- MEDIAL TEMPORAL CORTEX PATHOPHYSIOLOGY IN SCHIZOPHRENIA: ACTIONS OF ANTIPSYCHOTIC DRUGS (2008) (1)
- Savoxepine fails to selectively influence glucose metabolism in the rat limbic system (1994) (1)
- 10.3 INTRINSIC NEURAL ACTIVITY AS A BIOMARKER FOR DIFFERENTIAL TREATMENT EFFICACY IN PSYCHOSIS (2019) (1)
- Human brain receptors, III. Molecular Model: G protein-coupled receptor. (1994) (1)
- EMD 23,448: Effects of a putative dopamine autoreceptor agonist in chorea (2005) (1)
- Images in neuroscience. Human Brain receptors, VI. Ionotropic receptors. (1994) (1)
- Demonstrating drug action. (2004) (1)
- GABA agonist effect on cognitive dysfunction in schizophrenic subjects (1979) (1)
- Tau seeding without tauopathy (2022) (1)
- Abnormal limbic system connectivity in schizophrenia (2003) (1)
- Effects of Medication on Intrinsic EEG Activity: A BSNIP Study (2021) (1)
- Regulator of G protein signaling is a crucial modulator of antidepressant drug action in depression and neuropathic pain models(Proceedings of the National Academy of Sciences of the United States of America (2013) 110, 20 (8254-8259)) (2013) (1)
- 70 The effecf of chronic haloperidol treatment on dendritic spines in the rat striatum (1997) (1)
- Morphometric Attention and Language Brain Correlates in Early Psychosis With Cannabis Use and Polygenic Risk Score: A BSNIP Study (2021) (1)
- O3.4. PSYCHOSIS PHENOTYPES FROM B-SNIP FOR CLINICAL ADVANCES: BIOTYPE CHARACTERISTICS AND TARGETS (2020) (1)
- Neural Circuits in Schizophrenia-Reply (1994) (1)
- The Functional Involvement of the Anterior Cingulate Cortex in Schizophrenic Psychosis (2001) (1)
- Evaluating Clinical Trial Data From Schizophrenia Research (2001) (1)
- The human brain. (2004) (1)
- 5.3 Endophenotypes Guide Psychosis Neurobiology Formulations (2017) (1)
- The human genome sequence: the human genome I: chromosomes and protein coding. (2001) (1)
- 306 Effecfs of monetary reinforcement on verbal and visuospatial memory in schizophrenic subjects (1997) (1)
- Blockade of ketamine-induced psychosis: A human model for a new spectrum of antipsychotic activity? (2000) (1)
- SU5. Investigation of the Visual Steady-State Response in Schizophrenia, Schizoaffective, Psychotic, and Nonpsychotic Bipolar Disorders. (2017) (1)
- [125I]epidepride binding in post mortem brain of schizophrenic subjects (1995) (1)
- Images in neuroscience. Cortex,II: identifying lobes and landmarks. (1994) (1)
- PCP and antipsychotic drugs (1994) (1)
- Regional hippocampal abnormalities in schizophrenia: RCBF and neurochemical changes are confined to the anterior portion (2003) (1)
- HIV and AIDS. (2006) (1)
- State of DA/ACh balance after chronic treatment with haloperidol and with THIP in rats. (1984) (1)
- Neuroimaging, II; Regional Cerebral Blood Flow With H215O (1995) (1)
- Distribution of dopamine D2, D3 and D4 receptors in human post-mortem brain sections (1995) (1)
- Effects of Stimulus Repetition on Emotional Processing in Psychosis Biotypes: Findings From Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Consortium (2020) (1)
- 305 Comparison of hippocampal test performance in schizophrenic inpatients stabilized with typical antipsychotic medication and medication free (1997) (1)
- Cortex, IX. Heschl's gyrus and the planum temporale. (1995) (1)
- M94. Genetic Analyses of Cognitive Performance in Psychotic Disorders From the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Consortium (2017) (1)
- Clinical genetics, III: Alzheimer's disease: From genes to pathogenesis (1997) (1)
- The efficacy of the partial dopamine agonist (-)-3PPP in schizophrenia (1994) (1)
- Alzheimer's disease: From gene to pathology (1997) (1)
- Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives (2020) (1)
- Alterations in hippocampal function in schizophrenia: Its genetic associations and systems implications (2008) (1)
- 148. Auditory and Visual EEG Validators of Psychosis Biotypes, Findings From Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Consortium (2018) (1)
- Biomarker Profiles in Psychosis Risk Groups Within Unaffected Relatives Based on Familiality and Age. (2021) (1)
- Registration of MRI - PET Images, Procedure and Validation (1988) (1)
- 699 Effects of ketamine on eye tracking in schizophrenia and controls (1997) (1)
- O2.5. CORTICAL PATTERNING OF ABNORMAL MORPHOMETRIC SIMILARITY IN PSYCHOSIS IS ASSOCIATED WITH BRAIN EXPRESSION OF SCHIZOPHRENIA-RELATED GENES (2020) (1)
- Cerebral metabolic changes as a consequence of DA receptor blockade (1990) (1)
- -3PPP effects on local cerebral glucose utilization in the rat (1991) (1)
- The effects of ketamine and nicotine on brain function during cognition (2003) (1)
- 769 Chronic treatment of rats with sertindole and olanzapine produce low rates of oral dyskinesias (1997) (1)
- The long noncoding RNA FEDORA is a cell type– and sex-specific regulator of depression (2021) (1)
- 473 Regional correlations between ketamine-induced actions on psychosis and regional cerebral blood flow (rCBF) (1997) (1)
- Correlations between RCBF and behavior in drug-free schizophrenic patients (2003) (1)
- International Congress on Schizophrenia Research Introduction (2007) (1)
- Molecular biology, VI (1997) (0)
- SA94MACHINE LEARNING ANALYSIS OF ULTRA-DEEP WHOLE-GENOME SEQUENCING IN HUMAN BRAIN REVEALS SOMATIC GENOMIC RETROTRANSPOSITION IN GLIA AS WELL AS IN NEURONS (2019) (0)
- F190. Hippocampal Subfield Activity May Mediate Aspects of Psychosis (2018) (0)
- 205. Machine Learning to Further Improve Classification of Psychotic Disorders Using Clinical and Biological Stratification: Updates From the Bipolar Schizophrenia Network for Intermediate Phenotypes (BSNIP) (2017) (0)
- A Novel Role of the WNT-Dishevelled-GSK 3 Signaling Cascade in the Mouse Nucleus Accumbens in a Social Defeat Model of Depression Citation (2011) (0)
- Cortex, II: Identifying lobes and landmarks (1994) (0)
- Neuroendocrine defects in Huntington disease (1982) (0)
- Drug Evaluation Central & Peripheral Nervous Systems Olanzapine (Zyprexa): characteristics of a new antipsychotic (1997) (0)
- T47BRAIN ANGIOGENESIS INHIBITOR GENE IS ASSOCIATED WITH MODIFICATIONS OF EVENT RESPONSE POTENTIALS IN PSYCHOSIS (2019) (0)
- Visual encoding dysfunction in schizophrenic patients before and after learning, an event related FMRI study (2003) (0)
- Introduction Ten years: International Congress on Schizophrenia Research (1997) (0)
- Cell-Type Specific Epigenetic Links to Schizophrenia Risk in Control and Patients (2020) (0)
- 88 [3H]-Neurotensin receptor levels in human postmortem brain. Comparison of normals to schizophrenics off-, or on-antipsychotic drugs at death (1997) (0)
- APPLYING MULTIVARIATE TECHNIQUES, INCLUDING PARALLEL ICA TO COMMON COMPLEX PSYCHIATRIC ENDOPHENOTYPES (2017) (0)
- Hippocampal metabolic function in schizophrenia (1990) (0)
- Hippocampal Hyperactivity Emerges During a Critical Period in Mice (2021) (0)
- Time course of psychopathologic and dyskinetic motor changes after blind neuroleptic withdrawal (1991) (0)
- F185. The B-SNIP Biomarker Profiles in Clinically-Unaffected Relatives: Contributions of a Subjective Family History Report (2019) (0)
- Neuroanatomical Sex Differences in the Visual Cortex of Individuals With Psychosis: Findings From the Bipolar-Schizophrenia Network on Intermediate Phenotypes (2020) (0)
- Contents of the American Journal of Psychiatry (1996) (0)
- M61. Data-Driven Approach Identified Functionally and Physiologically Distinct Psychosis Subtypes. (2017) (0)
- Huntington ' s disease . growth hormone and prolactin in Twenty-four hour plasma levels of and (0)
- Transcriptional dissection of symptomatic profiles across the brain of men and women with depression (2023) (0)
- PrenatalTrainingonMothering Improvesthe Psychosocial Health of the Newborn/Child (2015) (0)
- Quantification of relative haloperidol occupancy and effects in vivo with a simple dual detector probe (1991) (0)
- TU53. EFFECTS OF CHILDHOOD TRAUMA AND CANNABIS ON THE ANTERIOR-POSTERIOR AXIS OF THE HIPPOCAMPUS IN A TRANSDIAGNOSTIC PSYCHOSIS SAMPLE: A BSNIP STUDY (2021) (0)
- in Acutely ill and Recovered Pa- tients W ith Major Depressive Disorder and Matched Healthy Com parison Subjects a (2012) (0)
- Effects of vasopressin on multiple fixed-ratio fixed-interval schedules of reinforcement (1985) (0)
- The statistical effects of different methods for controlling the global factor in PET-FDG imaging studies (1993) (0)
- Statistical parametric mapping of correlations between clinical symptoms and regional glucose metabolism in schizophrenics (1995) (0)
- High field MRS of glutamate and schizophrenia (2003) (0)
- Pharmacologic properties and antipsychotic effect of (-)-3PPP in schizophrenic patients (1993) (0)
- SEPARATING GLOBAL AND REGIONAL EFFECTS OF HYDROCORTISONE MEDICATION USING NORMALIZED FMRI (2010) (0)
- Brain Development, II: Establishing Synaptic Connections (1998) (0)
- A R T Ic Le (2011) (0)
- S188. Emotional processing in Bipolar Disorder With and Without Psychosis: Findings From the Psychosis and Affective Research Domains and Intermediate Phenotypes Consortium (2018) (0)
- The relationship between abnormal smooth pursuit eye movements and clinical variables in schizophrenic patients (1993) (0)
- 44. Transdiagnostic Relations Between Functional Brain Network Integrity and Cognition. (2017) (0)
- Disclosure of Editors' Financial Relationships. (2016) (0)
- O2.3. INCREASED PROTEIN INSOLUBILITY IN BRAINS FROM A SUBSET OF PATIENTS WITH SCHIZOPHRENIA (2019) (0)
- Serotonin binding sites and metabolites in the brain of schizophrenic suicide victims (1991) (0)
- rCBF pattern contrasts between normal volunteers and medication-free schizophrenics derived from a difficult tone recognition task (1996) (0)
- Behavioral / Systems / Cognitive Antidepressant Actions of Histone Deacetylase Inhibitors (2009) (0)
- 442 Comparison of striatal volumes in schizophrenic patients with and without eye tracking disorder (1997) (0)
- Cognitive Deficits and Their White Matter Correlates in Schizophrenia (2021) (0)
- SU83. Is the Anterior Splenium an Intermediate Phenotype Across the Psychosis Dimension (2017) (0)
- High dose PCP in rat PUP alters adult rat behavior (2003) (0)
- Oculomotor assessment in individuals with personality disorder (1989) (0)
- O9.5. EMOTIONAL SCENE PROCESSING IN PSYCHOSIS BIOTYPES: FINDINGS FROM THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (BSNIP) (2019) (0)
- SU68 COMMON VARIANTS OF NRXN1, LRP1B AND RORA ARE ASSOCIATED WITH INCREASED VENTRICULAR VOLUMES IN SCHIZOPHRENIA AND BIPOLAR DISORDER (2019) (0)
- Images in neuroscience. Neuroimaging, I.PET with [18F]fluorodeoxyglucose. (1995) (0)
- S162. Widespread Amygdala Nuclei Reductions Across the Psychosis Spectrum and in Their First-Degree Relatives: A BSNIP Study (2019) (0)
- Thalamic Nuclei Reductions Across the Psychosis Spectrum: A BSNIP Study (2020) (0)
- P597. Hippocampal Hyperactivity Can Be Generated by Dentate Gyrus Dysfunction During Adolescence (2022) (0)
- COST-EFFECTIVE FMRI NORMALIZATION IMPROVES DIFFERENTIATION BETWEEN SUBJECT CATEGORIES : THE FIRST CLINICAL DEMONSTRATION (2011) (0)
- 10. Brain Structure Biomarkers at the Psychosis/Nonpsychosis Interphase: Findings From the Bipolar–Schizophrenia Network for Intermediate Phenotypes (2017) (0)
- Presence of NMDA-R Antibodies in Schizophrenia (P4.187) (2018) (0)
- 486 Functional neuroanatomy of smooth pursuit eye movements in normal controls and schizophrenic patients (1997) (0)
- Contents of the American Journal of Psychiatry (2013) (0)
- Childhood Trauma And Cannabis Interactions In Affecting Psychosis Onset: Role Of The Anterior-Posterior Axis Of The Hippocampus and Differences In Cannabis Use Before or After Psychosis Onset (2022) (0)
- Endorphins in Mental Health Research (1981) (0)
- Schizophrenic symptom remission with apomorphine (1977) (0)
- Different deficits of cerebral function between schizophrenia and bipolar disorder : a resting-state functional MRI study (2012) (0)
- 850. Identification of Biotypes in Psychosis using Biomarkers and iPSCs (2017) (0)
- Correlation between changes in neurotransmitter receptor densities and chronic GABA agonist actions on haloperidol-induced vacuous chewing movements (1991) (0)
- Reduced cerebral glucose utilization in GABAergic nigral efferent target regions in intranigral isoniazid-induced vacuous chewing movements (1991) (0)
- Clinical and cognitive correlates of occulomotor abnormalities in schizophrenia (1990) (0)
- 373. Comparison of Childhood Trauma Among B-Snip Biotype Psychosis Groups (2023) (0)
- CNS volume 6 issue 1 Cover and Back matter (2001) (0)
- DEFICITS IN CK2-MEDIATED SYNTAXIN 1 PHOSPHORYLATION IN SCHIZOPHRENIA (2008) (0)
- 71-5 Treatment of primary negative symptoms (1997) (0)
- T173. Structural Amygdala Nuclei Abnormalities Distinguish Neurobiologically Derived Biotypes With Psychosis (2019) (0)
- A systematic mental health assessment of first-year students at a historically Black college. (2022) (0)
- New Options for the Treatment of Schizophrenia: A Clinical Review of the Three Most Recent Antipsychotic Drugs (2014) (0)
- Response time versus regional cerebral blood flow in deficit versus nondeficit schizophrenic patients (2000) (0)
- Late beta accentuation and decreased N2 amplitude to auditory oddball stimuli discriminate psychosis groups and co-occur in first-degree relatives (2012) (0)
- Auditory evoked oscillations discriminate major mood and psychotic diagnoses (2012) (0)
- Longitudinal brain imaging shows bariatric surgery-induced changes in areas associated with response inhibition/impulse control and self-monitoring (2017) (0)
- Characterization of childhood trauma, hippocampal mediation and Cannabis use in a large dataset of psychosis and non-psychosis individuals (2023) (0)
- The 43rd Annual Meeting of the Canadian College of Neuropsychopharmacology, November 4, 2021 (2022) (0)
- SA64. Hallucination Severity Predicted by Auditory Cortex Resting State Connectivity in Bipolar and Schizophrenia Network on Intermediate Phenotypes Study (2017) (0)
- Wayne Fenton's impact on academic neuroscience. (2007) (0)
- Antisaccade Speed-Performance Tradeoff in Bipolar Disorder (2021) (0)
- Impact of cocaine use on brain metabolism : hypoactivity , dose dependence , and relationship to cognitive ability (2012) (0)
- Early Change in Negative Bias After Antidepressant Treatment (2009) (0)
- Eye movement abnormality in schizoptypal personality disorder (SPD) (1990) (0)
- 114. What is New in the Treatment of Schizophrenia (2017) (0)
- Genome-Wide Association Studies Of Smooth Pursuit Eye Movements Across Psychotic Disorders: Preliminary Findings From The B-Snip Sample (2017) (0)
- 822. Abnormal Resting State Functional Connectivity in Bipolar Disorder with and without Psychosis (2017) (0)
- The glutamatergic system and schizophrenia (1995) (0)
- Emotional scene processing in biotypes of psychosis (2023) (0)
- 201. Stress Resilience vs. Vulnerability in Mood disorders, an Integrative Biological Approach (2019) (0)
- T176. Examining Retinal Nerve Fiber Layer Thickness and Microvascular Abnormalities in Psychosis With Swept Source OCT and OCT-A (2019) (0)
- Methods for diagnosis and therapy of schizophrenia (2003) (0)
- STRUCTURAL AND FUNCTIONAL NEUROIMAGING FINDINGS IN THE BSNIP PSYCHOSIS CONSORTIUM (2014) (0)
- Autism BrainNet. (2020) (0)
- 17 MACHINE LEARNING REVEALS BILATERAL DISTRIBUTION OF SOMATIC L1 INSERTIONS IN HUMAN NEURONS AND GLIA (2019) (0)
- Differing time course of emergence of psychotic symptoms and dyskinesia after neuroleptic withdrawal (1990) (0)
- Neurobiology of Schizophrenia (2002) (0)
- Pet-directed postmortem tissue analysis in schizophrenia (2000) (0)
- Smooth pursuit eye movements in schizophrenia spectrum disorders: Familial vs episodic (1991) (0)
- Registered PET-MRI comparative study of normal volunteers performing a tone discrimination task: the impact of performance error on cortical surface metabolic activity patterns (1991) (0)
- Cortex, I: In vivo visualization of the cortical surface (1994) (0)
- Prolonged hemodynamic response during incidental facial emotion processing in inter-episode bipolar I disorder (2013) (0)
- Perceptual skill and brain physiology in subgroups of persons with schizophrenia (2001) (0)
- Disclosure of Editors' Financial Relationships. (2018) (0)
- 842. Changes in Hippocampal Subfield Activity Contribute to Psychosis-Like Behaviors in Mice (2017) (0)
- Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disorders (2023) (0)
- Introduction (1999) (0)
- Putamen metabolic activity predicts dyskinesia severity in schizophrenic patients (1990) (0)
- Poster #S141 ASSOCIATIONS BETWEEN POLYGENIC RISK SCORES FOR TYPE 2 DIABETES MELLITUS AND CO-MORBID DIABETES IN A SAMPLE OF SUBJECTS WITH SCHIZOPHRENIA, SCHIZOAFFECTIVE, OR BIPOLAR I DISORDERS (2014) (0)
- P-15-17 Dopamine D2-family receptors in human postmortem brain: Comparison of normals and schizophrenics (1996) (0)
- First-episode psychosis: critical management issues during the first two years. (2001) (0)
- 146. Diagnosis and Biotype Comparisons Across the Psychosis Spectrum: Investigating White Matter Microstructural Differences From the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study Using Free-Water Imaging (2018) (0)
- Clinical and cortical similarities identified between bipolar disorder I and schizophrenia: A multivariate approach (2022) (0)
- Human brain receptors, II. G protein-coupled receptors. (1994) (0)
- 587 The treatment of schizophrenia with partial dopamine agonist: A promising strategy (1997) (0)
- Neuroendocrine Correlates in Neurology (1981) (0)
- Schizophrenia research series: from molecule to public policy. (1999) (0)
- Toward a Dimensional Understanding of Psychosis and Its Treatment (2014) (0)
- 62. Acoustic Startle Latency is Prolonged in Schizophrenia in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Cohort (2017) (0)
- Psychotic Disorders: Neurochemistry and Pharmacotherapy (2013) (0)
- 1637 – Recall Of Previously Learned Associations And Memory Generalization In Schizophrenia, Other Psychoses, Siblings, And Controls. The Northern Finland 1966 Birth Cohort Study (2013) (0)
- Alzheimer's dementia. (1995) (0)
- 145. Diagnosis and Biotype Comparisons Across the Psychosis Spectrum: Investigating Amygdala-Hippocampal Differences From the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study (2018) (0)
- 479 The methodological effects of repeated [15]O pet blood flow scans in schizophrenic and normal volunteers during rest and task performance (1997) (0)
- Schizophrenic psychosis: speculative new evidence to support the glutamatergic hypothesis of pathophysiology (1994) (0)
- Images in neuroscience. Neuroimaging, II. Regional cerebral blood flow with H2(15)O. (1995) (0)
- Contents of the American Journal of Psychiatry (1995) (0)
- 4. Asking questions about psychosis pathophysiology: In rats with PCP and in humans (1998) (0)
- 11. Extended Association Studies of Smooth Pursuit and Antisaccade Eye Movements: Findings From the B-SNIP Study (2017) (0)
- Editorial (1995) (0)
- SU25. Lack of Pupillary Modulation by Antisaccade Performance in Schizophrenia, Schizoaffective Disorder, and Psychotic Bipolar Disorder Suggests Reduced Top-Down Control During Response Preparation on an Executive Control Task (2017) (0)
- MOVEMENT DISORDERS AND PROXYSMAL DISORDERS (2002) (0)
- P523. Comparison of Lifetime Psychosis and Mood Symptoms in Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder With Psychotic Features (2022) (0)
- Diseases of the Mind and Brain: Overview (2002) (0)
- 68. Cognitive Burden of Anticholinergic Medications in Psychotic Disorders (2017) (0)
- 37. Reduced expression of PKC isozymes in the brains of teenage suicide victims (2000) (0)
- Social knowledge influences reasoning in cross-cultural studies involving differences in knowledge about social conduct and relationships (2014) (0)
- SU65. Neural Adaptation Differences Among Psychosis Biotypes (2017) (0)
- The Role of the Hippocampal Subfield System in Schizophrenia Psychosis (2012) (0)
- 161. Gyrification Abnormalities Across Psychotic Disorders: A Bipolar-Schizophrenia Network of Intermediate Phenotypes Study (2023) (0)
- 2007 in Review. (2007) (0)
- Anterior Default Mode Network Mediates the Relationship Between Systemic Inflammation and Cognition in Idiopathic Psychosis (2021) (0)
- 2008 in review (2008) (0)
- Quantitative Retinal Microvascular Analysis in Schizophrenia With Swept Source Optical Coherence Tomography Angiography (2021) (0)
- Jon M Stolk, PhD, MD (2007) (0)
- Welcome to the ACNP 43rd Annual Meeting (2004) (0)
- Schizophrenia research: The 11th congress on current research. March 28-April 1, 2007, Colorado Springs, CO, USA (2007) (0)
- rCBF pattern differences between schizophrenic patients with and without enduring negative symptoms (deficit symptoms) (1995) (0)
- T13 Gwas Of Bsnip Biofactors And Biotypes As Intermediate Phenotypes For Psychosis (2017) (0)
- 5.3 EVIDENCE ON A TRANSDIAGNOSTIC PSYCHOSIS SPECTRUM OF SCHIZOPHRENIA, SCHIZOAFFECTIVE AND PSYCHOTIC BIPOLAR DISORDER IN THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (B-SNIP) (2018) (0)
- Auditory and visual discrimination, a conjunction analysis of two difficult perceptual tasks (2000) (0)
- Neural White Matter Distinctions in Biologically Classified Psychosis (2018) (0)
- Social stress induces neurovascular pathology promoting depression (2017) (0)
- Identification of potential predictors of sertindole response in patients with schizophrenia (2007) (0)
- Changes in brain GAD mRNA in neuroleptic-treated rats (1995) (0)
- PET with [18F]fluorodeoxyglucose (1995) (0)
- 9.3 PSYCHOSIS BIOTYPES VERSUS CLINICAL SYNDROMES THROUGH THE PRISM OF INTRINSIC NEURAL ACTIVITY (2018) (0)
- 778 Neurochemical actions of typical and atypical neuroleptics in basal ganglia and thalamus (1997) (0)
- Phencyclidine produces distinct time-dependent regional alterations in four different immediate early genes in rat brain (1995) (0)
- 205 The effects of amphetamine, α-MPT, and antipsychotics on dopamine D2 receptor occupancy. An EEDQ study (1997) (0)
- Brain Development, IV: Axon Routing and Rerouting (1998) (0)
- Polygenic Risk for Cardiometabolic Disorders and Peripheral Inflammation in Psychosis (2021) (0)
- Clinical correlates of prolactin concentration in outpatient schizophrenics (1989) (0)
- Longitudinal Stability of EEG Psychosis Biomarkers: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) (2020) (0)
- POSTMORTEM BRAIN 5HT2 RECEPTORS IN SCHIZOPHRENIA: EFFECT OF NEUROLEPTICS AND SUICIDE (1992) (0)
- An important role for Cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors (2014) (0)
- 225. Tone recognition response time and cerebral blood flow: NV and SZ (1998) (0)
- Tracking DNA: The Southern blot (1997) (0)
- Three dimensional cortical surface morphometry and metabolism using registered magnetic resonance and position emission images (1989) (0)
- FUNCTIONAL STUDIES OF CHOLECYSTOKININ OCTAPEPTIDE IN MAMMALIAN CNS (1984) (0)
- Hippocampal Glutamate, Verbal Episodic Memory and Intrinsic Neural Activity in the Psychosis Spectrum (2021) (0)
- SU49. Do Psychosis Biotypes Differ Across Traditional Schizophrenia Subtypes (2017) (0)
- Therapeutic implications of dopamine D4 vs. D2 receptor selectivity and occupancy (1993) (0)
- From the Guest Editor: New Treatment Advances (2014) (0)
- Author Index Ablorh-Odjidja C: See Bass DM (2012) (0)
- Mental Illness in Hotel Residents (2013) (0)
- Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens (Science Translational Medicine (2010) 2, (62er4)) (2010) (0)
- Distribution and density of RGS4 MRNA in human postmortem brain sections (2003) (0)
- A-173 Grey Matter Volume, Psychotic Disorders, And Heredity of Alcohol Use Disorder: Reconceptualization by B-SNIP Biotypes (2022) (0)
- Extending Human Genome-Wide “Omics” Data With Mechanistic Studies in Rodent Models Identifies an Astrocyte-specific Mechanism of Orbitofrontal Cortex Dysfunction in Major Depressive Disorder (2023) (0)
- Glucose metabolism in deficit and non-deficit schizophrenic patients (1993) (0)
- GABA hypothesis of tardive dyskinesia: pharmacology (1989) (0)
- 2006 in review (2006) (0)
- S-13-4 Involvement of the nigral D1 receptor in neuroleptic-induced oral dyskinesias in rats: Clinical implications (1995) (0)
- SU54DEEP PHENOTYPING GENOME-WIDE ASSOCIATION STUDY IDENTIFIES GENETIC MARKERS ASSOCIATED WITH BRAIN VENTRICULAR ENLARGEMENT AS NEURODEVELOPMENTAL BIOMARKERS OF PSYCHOSIS (2019) (0)
- Changes in striatal ultrastructure in rats with haldol induced VCM's (1994) (0)
- O2.6. DELUSIONS ASSOCIATED WITH ABNORMAL FRONTOSTRIATAL EFFECTIVE CONNECTIVITY IN A SPECTRAL DCM ANALYSIS OF RESTING STATE FMRI (2020) (0)
- The Hippocampal Formation in Schizophrenia Mechanisms of Psychiatric Illness (2010) (0)
- The second international congress on schizophrenia research San Diego, California, April 1–5, 1989 (1989) (0)
- Intrinsic Activity Networks Differentiate Psychosis Biotypes (2020) (0)
- T170. Effective Multiple Test Correction (MTC) for GWAS With Large Numbers of Correlated Genotypes and Phenotypes (2019) (0)
- Frequency of Psychotic Symptoms in Schizophrenia ( WHO International Pilot Study ) (0)
- Characterizing Extracellular White Matter Pathologies Using Free Water Imaging Across the Schizophrenia Illness Course: A Multi-Site Harmonized Diffusion MRI Study (2021) (0)
- EFFECTS OF ANTIPSYCHOTIC DRUGS ON REGIONAL NEURONAL ACTIVITY AND ACTIVATION: ASL, VASO, AND fMRI BOLD (2008) (0)
- Social Stress Induces Blood-Brain Barrier Leakiness and Molecular Alterations Promoting Depression or Stress Resilience (2020) (0)
- Regional CBV Characteristics in Normal Subjects and its Relation to CBF : a VASO and ASL MRI study (2007) (0)
- Preliminary studies of altered synchronous gamma oscillatory activity in schizophrenia, bipolar disorder, and genetically high risk individuals under steady state response (2011) (0)
- Images in neuroscience. Clinical genetics, I. Huntington's disease: from disease to gene. (1997) (0)
- 266 The effects of ketamine on memory and other cognitive funcfions in schizophrenic patients and normal volunteers (1997) (0)
- SPINAL-REFLEX STUDIES AS TEST OF DOPAMINE NEUROTRANSMISSION (1978) (0)
- 92. Peripheral Oxytocin and Vasopressin Modulates Regional Brain Activity Differently in Men and Women With Schizophrenia (2017) (0)
- White matter abnormalities in persons with schizophrenia and psychotic bipolar disorder and their relatives (2011) (0)
- S.11.04 Are endophenotypes a useful concept? (2015) (0)
- Brief Report: Insight into Illness and Social Attributional Style in Asperger’s Syndrome (2012) (0)
- C.06.02 Predictors of individual response and long-term compliance in schizophrenia treatment (2007) (0)
- 197. Inflammatory Differences in Multilayer Functional Network Topology Impacts Cognition in Psychosis (2023) (0)
- T22. PITUITARY GLAND VOLUME DIFFERENCES IN INDIVIDUALS WITH PSYCHOSIS: RESULTS FROM THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (B-SNIP) STUDY (2018) (0)
- Novel Allele‐Specific Epigenetic Effects Shape Genetic Architecture in the Brain (2017) (0)
- rCBF pattern differences in trained normal volunteers and schizophrenic patients performing effortful tone recognition tasks (1995) (0)
- Oculomotor studies in schizophrenic patients with and without tardive dyskinesia (1991) (0)
- Neuronal gamma aminobutyric acid hypofunction in tardive dyskinesia cerebrospinal fluid gamma aminobutyric acid levels and saccadic eye movements (1986) (0)
- Dopamine agonist therapy of naturally occurring and drug-induced hyperkinetic extrapyramidal disorders (1979) (0)
- Reduced task-evoked pupillary response in preparation for an executive cognitive control response among individuals across the psychosis spectrum (2022) (0)
- An FMRI study of language organization in schizophrenia (2003) (0)
- Glutamate, glutamine, NAA, and GABA levels in hippocampus in schizophrenia as measured by 1H-MRS at 3T (2010) (0)
- Measures of Social Cognition The Wechsler ACS Social Perception Subtest : A Preliminary Comparison With Other (2012) (0)
- Ketamine Dose Response of Cortical rCBF (1998) (0)
- Deficit and non-deficit schizophrenia: Sleep, occulomotor amd MRI studies (1990) (0)
- 3.2 Can Neurobiological Subgroups in Psychotic Illness Advantage Drug DISCOVERY (2017) (0)
- NDT_A_308615 1621..1631 (2021) (0)
- 469 Ketamine induced cerebellarcingulate rCBF correlations and rCBF patterns in normal volunteers (NV) and schizophrenic patients (SZ) (1997) (0)
- 350 Implicit motor learning and memory in schizophrenia (1997) (0)
- Introduction: evaluating clinical trial data from schizophrenia research. (2001) (0)
- The genomic underpinnings of oscillatory biomarkers supporting successful memory encoding in humans (2019) (0)
- Factors predicting patient withdrawal from long-term treatment of schizophrenia (2007) (0)
- Schizophrenia, VII (2003) (0)
- The human genome sequence: the human genome ii: sources of genetic variation. (2001) (0)
- 5 – Neurophysiological and cognitive phenotypes across the schizophrenia–bipolar disorder boundary (2008) (0)
- 63 Symptoms cluster analysis on and off neuroleptic medication (1997) (0)
- Images in neuroscience. Cognition: interference. (2000) (0)
- Peripheral Inflammatory Markers Are Associated With Neural Activity During the Auditory Oddball Task (2021) (0)
- A-38Exploratory and Confirmatory Factor Analysis Converge on a Unitary Construct Underlying BACS Performance Across Psychotic Disorders, Their First-Degree Relatives, and Healthy Volunteers (2015) (0)
- Social recognition in mice: Behavioral disruption with ketamine and blockade with antipsychotic drug (2003) (0)
- Images in neuroscience. In vivo visualization of the cortical surface. (1994) (0)
- Brain development, VIII (1998) (0)
- CPNP 2019 Annual Meeting Poster Abstracts (2019) (0)
- P555. Early and Steady-State Visual Neuro-Oscillations Across the Psychosis Spectrum (2022) (0)
- Pharmacologic characterization of parallel cortical-subcortical circuits in schizophrenics with tardive dyskinesia (1993) (0)
- O11.4. DIAGNOSIS AND BIOTYPE COMPARISON ACROSS THE PSYCHOSIS SPECTRUM: INVESTIGATING WHITE MATTER MICROSTRUCTURAL DIFFERENCES FROM THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (B-SNIP) STUDY USING FREE-WATER IMAGING (2019) (0)
- Inter-Device Reliability of Swept Source and Spectral Domain Optical Coherence Tomography Retinal Structure Measurements in Schizophrenia (2021) (0)
- 108. Consolidation Across Multiple Levels of Analysis for Parsing Biological Heterogeneity in Psychosis (2018) (0)
- Drs. Tamminga and Chase Reply (1979) (0)
- Cortex, VII: The hippocampus in epilepsy (1995) (0)
- 493 Ketamine induced time effect by principal component analysis (1997) (0)
- 292 Response Time (RT) and the odds of making a correcf choice (1997) (0)
- Brain Development, III: Cerebral Cortex (1998) (0)
- 2010 in Review. (2010) (0)
- TOWARDS PERSONALIZED MEDICATION IN SCHIZOPHRENIA: HYPOTHESIS-GENERATING FINDINGS ON PREDICTORS OF TREATMENT RESPONSE AND WITHDRAWAL (2008) (0)
- B-SNIP Psychosis Biotypes: Replication and Validation (2021) (0)
- Genetic Topography of Cortical thickness: A BSNIP Study (2020) (0)
- 965. Investigating Brain Structure Across Bipolar Disorder Subtypes: Findings from the Psychosis Affective Research Domain Intermediate Phenotypes (PARDIP) Study (2017) (0)
- 572. Cannabis Use and Matrix Metalloproteases in Schizophrenia (2017) (0)
- Longitudinal Stability of Psychosis Biomarkers: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) (2021) (0)
- Remoxipride therapy in poorly responsive schizophrenics (1991) (0)
- Serotonin binding sites in the brain of schizophrenic suicide victims (1993) (0)
- Intrinsic activity of dopamine agonists and partial agonists at the cloned dopamine D4.4 receptor (1995) (0)
This paper list is powered by the following services:
Other Resources About Carol Tamminga
What Schools Are Affiliated With Carol Tamminga?
Carol Tamminga is affiliated with the following schools:
